Is unexplained elevated maternal serum alpha-fetoprotein still important predictor for adverse pregnancy outcome?
dc.contributor.author | Başbuğ, Derya | |
dc.contributor.author | Başbuğ, Alper | |
dc.contributor.author | Gülerman, Cavidan | |
dc.date.accessioned | 2020-04-30T23:18:47Z | |
dc.date.available | 2020-04-30T23:18:47Z | |
dc.date.issued | 2017 | |
dc.department | DÜ, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü | en_US |
dc.description | WOS: 000405108100009 | en_US |
dc.description | PubMed: 28727133 | en_US |
dc.description.abstract | Objectives: The purpose of this study was to determined the predictive value of maternal serum alpha-fetoprotein (MSAFP) as a marker for adverse pregnancy outcomes. Material and methods: This study was carried out at Dr. Zekai Tahir Burak Women's Health Education and Research Hospital between 2009 and 2010. This study included a total of 1,177 pregnant women, including 170 in the study group and 1,007 in the control group. Pregnancy outcomes and characteristics were analyzed with regard to the MSAFP value. Results: Gestational week, birth weight and APGAR scores were significantly lower in the elevated MSAFP group (p < 0.001). Adverse pregnancy outcomes, such as preterm delivery, preterm premature rupture of membranes (PPROM), oligohydramnios and intrauterine growth restriction (IUGR) rates were increased in the elevated MSAFP group. Conclusions: Although ultrasound outweighs as a screening method for neural tube defects and non-invasive prenatal testing outweighs for aneuploidy screening MSAFP level in the second trimester is still an important predictor for poor maternal/fetal outcomes. | en_US |
dc.identifier.doi | 10.5603/GP.a2017.0061 | en_US |
dc.identifier.endpage | 330 | en_US |
dc.identifier.issn | 0017-0011 | |
dc.identifier.issn | 2543-6767 | |
dc.identifier.issue | 6 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 325 | en_US |
dc.identifier.uri | https://doi.org/10.5603/GP.a2017.0061 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12684/3521 | |
dc.identifier.volume | 88 | en_US |
dc.identifier.wos | WOS:000405108100009 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | en | en_US |
dc.publisher | Via Medica | en_US |
dc.relation.ispartof | Ginekologia Polska | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | alpha-fetoprotein | en_US |
dc.subject | adverse pregnancy outcome | en_US |
dc.subject | prenatal tests | en_US |
dc.title | Is unexplained elevated maternal serum alpha-fetoprotein still important predictor for adverse pregnancy outcome? | en_US |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1
Yükleniyor...
- İsim:
- 3521.pdf
- Boyut:
- 143.31 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin / Full Text